PML/RARA Quantitative, PCR
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Diagnosis of acute promyelocytic leukemia (APL)
Detection of residual or recurrent APL
Monitoring the level of promyelocytic leukemia/retinoic acid receptor alpha (PML/RARA) in APL patients
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
See Acute Promyelocytic Leukemia: Guideline to Diagnosis and Follow-up in Special Instructions.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Quantitative, Real-Time Polymerase Chain Reaction (PCR)
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Acute myeloid leukemia (AML)
Acute promyelocytic leukemia (APL)
AML (acute myeloid leukemia)
APL minimum residual disease